SynthesisSystematic reviews2026
Exploring gut microbiome dysbiosis in vasculitis in adults: a systematic review.
Synthesis in Systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimAlthough studies have confirmed that disruptions in the gut microbiota (dysbiosis) contribute to the development of autoimmune disorders, the precise pathways through which the gut microbiota influences the onset and progression of vasculitis remain largely unknown. In recent years, research has increasingly concentrated on assessing the contribution of the gut microbiota to vasculitis. This systematic study sought to assess the dominant gut microbiota profiles in vasculitis patients and compare them to those of healthy individuals.
methodsThe Cochrane methodology was used to design and conduct the present systematic review. Relevant articles published up to May 2025 were searched and collected from four electronic databases: PubMed, Scopus, Medline, and Web of Science. The keywords used in the search included "vasculitis," "Takayasu arteritis," "giant cell arteritis," "polyarteritis nodosa," "microscopic polyangiitis," "granulomatosis with polyangiitis," "eosinophilic granulomatosis with polyangiitis," "cryoglobulinemic vasculitis," "IgA vasculitis," "variable vessel vasculitis," "Behçet's disease," and "Cogan's syndrome" alongside phrases like "gut microbiome," "gut microbiota," and "gut flora."
resultsOverall, 12 publications were included in the analysis. Three addressed individuals with Takayasu arteritis (TAK), three investigated ANCA-associated vasculitis (AAV), another three examined Behçet's disease (BD), while one study each pertained to IgA vasculitis (IgAV), Kawasaki disease (KD), and a nonspecific form of vasculitis. The majority of these works observed variations in both α-diversity and β-diversity, as well as in the diversity and richness of the gut microbiota. Additionally, the structure of the microbial communities differed markedly between those with vasculitis and healthy individuals. Notably, Bacteroidetes, Firmicutes, and Proteobacteria-the dominant bacterial phyla in the human gastrointestinal tract-were frequently diminished in affected patients.
conclusionThe occurrence of intestinal microbial imbalance in individuals diagnosed with vasculitis has been validated. As observed in various other autoimmune conditions, the gut microbiota of vasculitis patients is chiefly comprised Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria. Disruptions in the microbial ecosystem-mainly typified by diminished diversity and population density-may play a role in triggering and advancing the disease. SYSTEMATIC REVIEW REGISTRATION: This review was not registered.
Indexed as
Identifiers
42888447What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.